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Abstract
Background: This study describes the laboratory evaluation of a novel diagnostic platform for malaria. The
Magneto Optical Test (MOT) is based on the bio-physical detection of haemozoin in clinical samples. Having an
assay time of around one minute, it offers the potential of high throughput screening.
Methods: Blood samples of confirmed malaria patients from different regions of Africa, patients with other
diseases and healthy non-endemic controls were used in the present study. The samples were analysed with two
reference tests, i.e. an histidine rich protein-2 based rapid diagnostic test (RDT) and a conventional Pan-Plasmodium
PCR, and the MOT as index test. Data were entered in 2 × 2 tables and analysed for sensitivity and specificity. The
agreement between microscopy, RDT and PCR and the MOT assay was determined by calculating Kappa values
with a 95% confidence interval.
Results: The observed sensitivity/specificity of the MOT test in comparison with clinical description, RDT or PCR
ranged from 77.2 - 78.8% (sensitivity) and from 72.5 - 74.6% (specificity). In general, the agreement between MOT
and the other assays is around 0.5 indicating a moderate agreement between the reference and the index test.
However, when RDT and PCR are compared to each other, an almost perfect agreement can be observed (k =
0.97) with a sensitivity and specificity of >95%.
Conclusions: Although MOT sensitivity and specificity are currently not yet at a competing level compared to
other diagnostic test, such as PCR and RDTs, it has a potential to rapidly screen patients for malaria in endemic as
well as non-endemic countries.
Background
Initiation of malaria treatment largely depends on good,
laboratory confirmed diagnosis. However, in many dis-
ease endemic countries clinical diagnosis is the only
method used to decide whether or not to treat, since
laboratory techniques to confirm the clinical suspicion
are considered to be too labour-intensive or not sensi-
tive enough [1,2]. In general, screening of blood slides
by microscopy is still considered to be the “gold stan-
dard”. This method is cheap and simple but labour
intensive, time consuming and requires well-trained
personnel that can differentiate between the different
Plasmodium species [3]. In recent years, a variety of
rapid diagnostic tests (RDTs), detecting circulating
Plasmodium antigen(s) in the blood of a patient, has
been developed for the diagnosis of malaria and are cur-
rently rolled out by the World Health Organization
(WHO) [4]. These tests are fast, easy to perform and do
not require electricity or specific equipment [5-7], but
may be limited in sensitivity (detecting only parasitaemia
levels above 200 parasites/μl blood) and concerns have
arisen about their stability [8]. Alternative platforms to
detect malaria are, therefore, still being developed.
One such platform for the fast (less than one minute)
and easy detection of malaria parasites in a patient
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Depending on its final sensitivity and specificity, the
MOT could potentially be used as a diagnostic device in
resource limited settings because of its robustness and
the potential of working without electricity (as it can
operate on a solar battery) or the need of a cold chain.
I tw o u l da l s ob es u i t a b l ef o rt h es c r e e n i n go fr e t u r n i n g
travellers, military personnel returning from a mission
or the detection of asymptomatic carriers in a cross sec-
tional or epidemiological survey because of its high
throughput nature and limited costs. The MOT princi-
ple is based on the following: after invasion of malarial
parasites into erythrocytes, Plasmodium parasites digest
the globin part of haemoglobin. The haem component,
which is toxic to the parasite, is converted into haemo-
zoin in the form of rod shaped nano-crystals which, if
found in a patient, are indicative of malaria infection.
Haemozoin is paramagnetic, i.e. it has a small and posi-
tive susceptibility to externally applied magnetic fields
under the action of which it develops a small magnetic
moment that is not retained when the field is removed
[10-12]. When a magnetic field is applied across a
potentially infected sample any haemozoin crystals pre-
sent align within the field whereas in the absence of a
field the crystals remain free to orient randomly under
the thermal energy of their immediate environment
[10-12]. This phenomenon, which is correctly referred
to as the Cotton-Mouton effect, can be used to differ-
entiate between a sample containing haemozoin and one
without (Figure 1). Laser-based instrumentation able to
quantify this phenomenon (Figure 2) has previously
shown promising results when attempting the diagnosis
of malaria in an experimental setup [9]. To further eval-
uate the potential of this technology a more elaborate
prototype MOT device has been built by one of the
partners in the EU sponsored project: “Novel Magneto-
Optical Biosensors for Malaria Diagnosis” (the European
Commission Framework 6 Programme contract:
016494). This device was extensively evaluated in a
laboratory-based trial using a broad spectrum of stored
clinical samples and its performance is reported here.
Methods
Study population
The study population (Table 1) comprised blood sam-
ples (N = 217) obtained from patients visiting various
health clinics in disease endemic countries (Sudan,
Nigeria, Tanzania, Vietnam) or from returned travellers
visiting the outpatient clinic of the Academic Medical
Centre (Amsterdam, The Netherlands). All malaria
patients were physically examined by experienced medi-
cal doctors and a confirmed diagnosis was obtained for
each patient by reading of Giemsa-stained slides accord-
ing to WHO recommendations [13]. Healthy control
samples were obtained from 100 blood donations at the
Sanquin blood bank in Amsterdam, The Netherlands.
By the criteria used to select blood donors (i.e. no physi-
cal complaints, no stay in malaria endemic countries for
the last five years), it was ensured that these can be con-
sidered malaria negative. A small subset of samples with
other diseases was included to measure specificity. All
patients consented to participate in the study and ethical
clearance from the appropriate authorities was obtained
when necessary.
Sample collection and handling
From all patients and controls, 2 ml of venous EDTA
blood was collected for DNA extraction and PCR analy-
sis, immunochromatic histidine rich protein-2 (HRP-2)
detection and MOT analysis. After collection the blood
was stored at -20°C until further use. All blood samples
were examined for the presence of Plasmodium DNA
by conventional PCR detecting all four human plasmo-
dium species, Plasmodium falciparum, Plasmodium
vivax, Plasmodium ovale and Plasmodium malariae as
described in previous publications and with a human
household gene GAPDH to control for isolation and
amplification [14]. If no internal control appeared after
amplification the PCR reaction was scored as invalid.
The presence of HRP-2 indicating an active or recently
passed infection with malaria was detected in 5 μl blood
by an immunochromatic assay (RDT) (Paracheck,
Orchid Biomedical Systems, Verna, Goa, India), accord-
ing to the manufacturer’s instructions and read after 15
minutes by two independent scientists. Both the RDT
and PCR reactions were performed independently by
experienced laboratory technicians familiar with the
respective tests. Data was scored on a data sheet and
communicated to the data manager who entered the
data into the database.
MOT analysis
All analytical MOT measurements were taken using an
experimental instrument having the same specifications
and operational methodology described previously
(figure 3) [9]. Prior to analysis, the samples were thawed
and 100 μl transferred to an Eppendorf tube together
with 400 μlc e l ll y s i sb u f f e r( p H7 . 5T r i s / H C l5 0m M ,
NaCl 150 mM, Nonidet P40 1%, Sodium deoxycholate
0.5%) before sonicating for 10 seconds. After processing
in this manner samples were immediately passed to the
MOT instrument operator, an experienced physicist
blinded from the available clinical and diagnostic infor-
mation, who transferred 150 μlo fe a c ht oo n eo ft h e
glass bottomed sample cells used by the instrument.
The cells were then introduced into the instrument and
the measurement sequence for the Cotton-Mouton
effect initiated. The magnitude of the Cotton-Mouton
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in the blood sample. A value measured above the noise
floor of the instrument is positively indicative of malaria.
The results of MOT testing (i.e. positive or negative)
were communicated to a data manager who entered the
information into the database.
Calibration of the MOT instrument was by a serial
dilution of b-haematin in phosphate buffered saline
(PBS) prior to the initial testing of the patient samples.
The instrument is sensitive to the presence of haemo-
zoin in the blood down to concentrations of 5 ng/μlo r
better which as discussed in [9] is considered to be
equivalent to between 50 and 100 parasites/μl
Statistics
Before final analysis of the data, samples for which
insufficient clinical or analytical information was avail-
able were removed from the study. Microscopy
performed at initial diagnosis is considered as the
golden standard for malaria diagnosis. Results of the
MOT assay are consequently tested against this standard
and also compared to the RDT and PCR obtained data.
Data were entered in 2 × 2 tables and analysed for
sensitivity (i.e. the probability that the assay will be
positive when the infection is present) and specificity
(i.e. the probability that the assay will be negative when
the infection is absent) using the formulas:Sensitivity=TP/
(TP+FN)×100% and Specificity=TN/(TN+FP)×100%
In the equations above, TN represents true negative,
TP true positive, FN false negative and FP false positive.
In addition likelihood ratios (LR) were calculated. The
agreement between microscopy, RDT and PCR and the
MOT assay was determined by calculating Kappa values
with a 95% confidence interval [15] using Epi-info ver-
sion 6. Kappa values express the agreement beyond
chance and a kappa value of 0.21-0.60 is a moderate, a
Figure 1 (a) Schematic diagram of the diagnostic device, a sample cell containing a lysed blood sample is placed within the poles of
a magnet supplying a magnetic field up to 0.6 Tesla. A polarised laser beam passes through the sample and the transmitted intensity is
recorded using a photodetector. The intensity is recorded against time with and without a magnetic field. If haemozoin crystals are present, the
transmitted intensity is magnetic field dependent. (b) When no magnetic field is applied, crystals are randomly orientated and a base line
intensity is recorded (c) In a magnetic field, the crystals become aligned along the direction of applied field, inducing as an increase in recorded
intensity [9].
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almost perfect agreement beyond chance.
Results
In this retrospective laboratory-based evaluation, a total
of 217 samples were analysed with three reference tests
and the MOT as index test. Samples were collected in
2008 and analysed with MOT in July 2009. In total, 84
samples out of the 217 were confirmed (either
microscopy or, in the case of the sickle cell patients,
RDT and PCR positive) malaria positive. Parasitaemia of
the positive samples ranged from 600 parasites/μlt o
85,500 parasites/μl. When these samples were tested
with MOT, 65 were scored positive (see Table 2). Seven
of the samples analysed with MOT were inconclusive.
However, in all the comparisons, the inconclusive results
were regarded as negative. Omitting the inconclusive
samples from the analysis did not give a significant dif-
ference. Of the 133 confirmed negatives, 100 were
found negative with MOT giving a sensitivity of 78.3%
and a specificity of 74.4%.
Also a direct comparison between the different alter-
native diagnostic methods (RDT and PCR) and MOT
was done. When RDT results were compared to MOT,
a sensitivity of 77.2% and a specificity of 72.5% were
observed for the MOT test. For PCR, one sample could
not be analysed, because the internal control was not
amplified, leaving 216 samples for further analysis. If the
inconclusive MOT results are not taken into considera-
tion, then a sensitivity of 78.8% was found and a specifi-
city of 74.6% for the MOT test.
Of the 30 samples from endemic negative controls,
seven samples were found false positive with the MOT
test while being negative with all other employed tests;
they originated from Sudanese sickle cell patients. The
Sudanese malaria confirmed patients that were missed
in the MOT test (n = 17) had a parasitaemia ranging
from 5,680 to 78,000 parasites/μl (mean: 32,615 para-
sites/μl). One sample from Vietnam missed with the
MOT analysis had a parasitaemia of 10,000 parasites/μl.
One sickle cell patient that was found positive with
RDT and PCR for malaria was scored inconclusive with
MOT.
In general with all comparisons, the agreement
between MOT and the other assays was around 0.5,
indicating a moderate agreement between the reference
and the index test. However, when RDT and PCR were
compared to each other only three samples out of the
216 samples that could be compared were discordant
(two PCR negative RDT positive and one vice versa). Of
the other samples 135 were negative by both tests and
78 positive by both tests thus showing an almost perfect
agreement (k = 0.97), with a sensitivity and specificity of
over 95% indicating that the reference tests are perform-
ing at a competing level. For a complete overview
and statistical analysis of the different comparisons see
Table 2, Table 3, Table 4 and Table 5.
Discussion
This paper describes an extensive laboratory evaluation
of a new and very rapid technology for the diagnosis of
malaria by detecting the presence of haemozoin in the
blood sample of suspected patients. Although several
Table 1 Overview of samples included in the evaluation
of the MOT device
Clinical description Country of
Origin
Number used for
analysis
Healthy controls The
Netherlands
100
Microscopically confirmed malaria
cases
Sudan 72
Microscopically confirmed malaria
cases
Vietnam 8
Sickle cell anaemia patients* Sudan 20
Sickle cell anaemia patients Nigeria 5
Sickle cell anaemia patient Tanzania 1
Arthritis patients Tanzania 2
B-Thallesemia patients Tanzania 2
Visceral leishmaniasis patients
(returning travels)
The
Netherlands
7
Total 217
* This set of samples was not analysed with microscopy, however RDT and
PCR testing gave evidence that 3 patients in this group were in fact also
suffering from a malaria infection.
Figure 2 Overview of the MOT diagnostic device, showing the
main components including the optical head, magnet, sample
cell inlay and computer controlled unit.
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of the malarial pigment in a patient’s blood have been
explored in recent years this present technique uniquely
utilises the magneto-optical properties of the blood-hae-
mozoin system.
Automated blood count machines, such as Cell-Dyn®
(Abbot, Santa Clara, California) utilize flow cytometry
techniques to detect haemozoin-containing monocytes
(PCM) during routine full blood count (FBC) in
research settings but have not been applied in medical
practice [16-18]. Such technology performs cell-by-cell
analysis of the optical scattering properties of circulating
cell suspension yielding information on cell size, internal
structure, granularity and surface morphology. FBC
results are analysed by visual inspection of granularity/
lobularity plot on the instrument’s display monitor with
Figure 3 Photographs of the measurement platform (a) and measurement procedure (b-d). (b) The operator loads an empty sample cell
within the device’s loading mechanism, (c) a lysed blood sample (150 μl) is pipetted into the sample cell, (d) the sample cell is placed within
the magnet using the sample loading mechanism. Once the loading procedure is complete an automated measurement routine can be initiated
via the dedicated control software. Typical data output is shown in (e), recorded from a 32,500 parasites/μl sample and clearly showing an
intensity change; regions of maximum signal coincide with an applied magnetic field while regions of minimum signal are recorded with no
applied field.
Table 2 Results of confirmed malaria samples in
comparison to the MOT results
Confirmed Malaria
Positive Negative Total
Positive 65 33 98
MOT Negative 19 100 119
Total 84 133 217
Table 3 Overview of the RDT results in comparison to the
MOT results
RDT
Positive Negative Total
Positive 61 36 97
MOT Negative 19 101 120
Total 80 137 217
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sent an HZ containing monocyte. In small trials [16-18],
s a m p l e sf r o me n d e m i cc o u n t r i e ss u f f e r e df r o mp e r s i s t -
ing haemozoin-containing white blood cells that resulted
in false positive observations and, therefore, the true
sensitivity and specificity of these automated methods
still have to be confirmed. Significant adjustments to the
current software and measurement algorithm of these
apparatus have to be implemented to ensure user-
friendliness and flag suspicious samples more clearly
[18] while extending the measurement to a greater num-
ber of cells [19]. However, it is deemed unlikely [20]
that the cost (~$40,000), complexity and physical size of
commercial flow cytometers will ever decrease suffi-
ciently to get such apparatus to the resource-poor areas
most affected by malaria where it is needed. In contrast,
the MOT test accesses the total haemozoin load from a
given blood sample, including PCM and PRBC, by per-
forming a volumetric test using an apparatus whose
relatively simpler measurement principle lends itself to
the production of a rapid portable, battery operated
point-of-care device at costs one or two order of magni-
tude lower than currently available Cell-Dyn® apparatus.
The MOT test described has been extensively tested
in the present study on a large sample set of positive
and negative samples and the results were compared
against microscopy, RDTs detecting HRP-2 antigen and
PCR. The performance, in terms of sensitivity and speci-
ficity, of RDT and PCR employed in the present evalua-
tion was good since there was an almost perfect
agreement between the comparative tests. The observed
sensitivity/specificity of the MOT test in comparison
with clinical description, RDT or PCR ranged from 72.5
- 74.6% (specificity) and from 77.2 - 78.8% (sensitivity)
with a very low positive likelihood ratio between 2.8 and
3.0. Although in other studies false positivity is often
attributed to circulating antigen from cleared parasites,
this can in the present study only explain seven of the
false positive samples. All these samples were obtained
form Sudanese sickle cell patients that were negative
with the other employed tests. It remains unclear
whether the false positivity is caused by circulating anti-
gen or is influenced by their sickle cell trait and this
should be studied further on a larger set of samples of
malaria negative endemic controls. The other false posi-
tive samples were obtained from healthy non-endemic
controls. These non-endemic samples were obtained
from healthy donors of the Dutch blood bank who have
not traveled to a malaria endemic country within the
last five years before their donation. The false positivity
of this specific group of samples is concerning but is
possibly attributable to contaminant structures intro-
duced during the hand assembly of the sample cells
which is currently conducted without quality control.
Cells are fabricated from two components a thin glass
window (7 mm in diameter) and a carbon injection
moulded cylinder. The single use disposable cell is
formed by using pre-cut adhesive inserts to cement the
glass window to the cylinder. Although all sample cells
were only used once and no contaminants form other
samples could explain the false positivity, other contami-
nants introduced during assembly process, for example
particles from the environment, which are free and able
to respond to the application of a magnetic field will
generate a false signal. Problems associated with sample
cells can ultimately be easily addressed by employing an
automated assembly and quality control procedure
whilst further study on the response of various lysis buf-
fers to magnetic field will fully characterize and possibly
reduce their magneto-optical contribution such that
changes to the measurement algorithm may be imple-
mented to significantly reduce false positivity.
A substantial number (n = 19) of malaria confirmed
cases are being missed by the MOT test. These samples
all had a parasitaemia above 1,000 parasites/μla n d
should be readily detectable by the MOT instrument,
which has an estimated analytical sensitivity of between
50 and 100 parasites/μl. There are several possible
explanations for these false negatives; the most obvious
being associated with the fact that the MOT diagnostic
process was developed and calibrated using fresh blood
Table 4 Overview of the PCR results in comparison to the
MOT results
PCR
Positive Negative Total
Positive 63 34 97
MOT Negative 19 100 119
Total 82 134 216
Table 5 Statistical analyses of the different comparisons excluding inconclusive PCR or MOT results
comparison Sensitivity in %
(95% CI)
Specificity in %
(95% CI)
+ Likelihood ratio
(95% CI)
- Likelihood ratio
(95% CI)
Agreement
%
k-value
Confirmed vs MOT 78.3 (68.3-85.8) 74.4 (65.8 -80.9) 3.0 (2.2-4.1) 0.2 (0.2-0.5) 75.7 0.51
RDT vs MOT 77.2 (66.8-85.1) 72.5 (64.3-79.4) 2.8 (2.1-3.8) 0.3 (0.2-0.5) 74.3 0.48
PCR vs MOT 78.8 (66.6-84.6) 74.6 (66.6-81.2) 3.0 (2.2-4.1) 0.3 (0.2-0.5) 75.1 0.49
PCR vs RDT 98.7 (93.2-99.8) 98.5 (94.8-99.6) 67.6 (17.1-267.8) 0.03 (0.02-0.09) 98.6 0.97
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tized red blood cells. The samples used in the present
study had been stored at -20°C before testing and some
had been freeze thawed several times. This may have
caused agglutination of haemozoin crystals resulting in a
non-homogenous sample and thus not representative
anymore for the original sample. Furthermore, if the
agglutinated crystals are not fully sonicated the mobility
of the haemozoin under action of the magnetic field will
be impaired. Either or both these effects could result in
the Cotton-Mouton signal massively under representing
the mass of haemozoin present and thus might result in
a false negative signal. A second factor that currently
further complicates the relationship between parasitae-
mia and haemozoin and which might also lead to false
positivity or false negativity is the wide variation of hae-
matocrit levels between patients. These can result in
patients sampled at the same point in the parasites life
cycle and found to have identical levels of parasitaemia
registering vastly different levels of haemozoin. Varia-
tions in haematocrit also impact adversely on the mea-
surement procedure by producing corresponding
variations in sample transmittance and hence in the sig-
nal level and dynamic range recorded at the optical
detector. None of the above issues are currently allowed
for by the decision-making algorithms of the MOT
instrumentation. Attention is drawn however to the
point that although presented as a screening device,
with a positive or negative diagnostic output, the MOT
technique in returning a magneto-optic signal propor-
tional to the haemozoin concentration (as evidenced by
calibration data) together with an optical signal propor-
tional to the haematocrit, offers a means of studying the
complex inter-relationship between haemozoin, parasi-
taemia and haematocrit in blood samples. This may
allow correlating haemozoin concentration against para-
sitaemia for the widest range of haematocrit levels
experienced in practice. If necessary this process can be
further extended to include the impact of other disease
states such as anaemia on diagnostic sensitivity. These
clinical parameters could be programmed into the deci-
sion-making algorithms of future MOT instrumentation
and may substantially improve the performance of the
instrument with respect to false reporting.
A commercially viable product must be able to com-
pete with RDT and microscopy and the current sensitiv-
ity/specificity and predictive value of MOT is not yet at
an appropriate level.
The principle limitations of the current study are the
lack of fresh samples, lack of information on haemozoin
and haemoglobin levels that may influence the outcome
of the result, the limited amount of endemic controls
and the influence of hand assembly of the sample cells
making it difficult to asses the true potential of the
device. These issues can however easily be addressed in
a future trail. Having a large range of samples from the
same setting with known malaria prevalence could give
a better indication on its positive and negative predictive
value which is not possible with the current sample set.
It is however very promising that the device has been
designed and assembled in less than 3 years after the
initial idea with still potential for substantial improve-
ment in the design of the hard- and software. The sim-
plicity of the device, low costs (a sample cell will only
cost 25 euro cents), the straightforward operation with a
limited number of handling steps and the possibility to
operate the instrument without a constant supply of
network electricity (i.e. it can operate on a battery) com-
bined with the short assay time of 1 minute creates a
technology with great potential for simple malaria
screening in malaria endemic as well as non endemic
countries.
Conclusion
This paper describes the evaluation of a novel and very
rapid diagnostic device based Magneto Optical Technol-
ogy (MOT) for the diagnosis of malaria by detecting
haemozoin in a small patient blood sample. The MOT
technology has been evaluated on a large panel of stored
blood samples. Although the sensitivity and specificity
are not yet at a competing level compared to other diag-
nostic test, such as microscopy and RDTs, it has a
potential to rapidly screen patients for malaria in ende-
mic as well as non-endemic countries. Therefore, the
technique should be evaluated on a panel of fresh blood
samples after the necessary adaptations of the device’s
algorithm.
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